This trial will focus on improving the health of older Veterans and those recovering from COVID-19 by developing rehabilitation therapies to improve vascular endothelial function.
3 Primary · 0 Secondary · Reporting Duration: Baseline, months 3 and 6, and every 6 months thereafter until the end of year 4.
300 Total Participants · 2 Treatment Groups
Primary Treatment: Mitoquinone · Has Placebo Group · N/A
Age Any Age · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: